About Us

In 2002 the Bill and Melinda Gates Foundation’s Global Health Programme granted a £20 million award to establish the SCI at Imperial College London. The award has been directed to delivering treatment for schistosomiasis and intestinal worms to millions of sub-Saharan Africans at high risk of serious disease.

In 2006, the SCI was a founding partner of the Global Network for Neglected Tropical Disease Control (GNNTDC) and expanded its remit to integrating the control or elimination of seven NTDs.

By 2007, the SCI has facilitated delivery of approximately 40 million treatments of praziquantel against schistosomiasis, and many more deworming doses of albendazole. We have helped six countries establish national control programmes, and several other countries implement smaller pilot projects.

The American people, through the United States Agency for International Development (USAID) , are now supporting SCI and others to further integrated NTD control in eight countries, while Geneva Global (an international philanthropy company) is funding SCI to promote integrated NTD control in Rwanda and Burundi. Through integration SCI and its partner organisations cut costs, avoid duplication and expand coverage to treat many more vulnerable people.